Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

P.M. Forde | Researchclopedia

Back to researchers

P.M. Forde

Sidney Kimmel Comprehensive Cancer Center

6

Works

10

Citations

1

h-index

0

i10-index

Research Topics

Cancer Immunotherapy and Biomarkers Lung Cancer Treatments and Mutations Lymphoma Diagnosis and Treatment

Affiliations

Johns Hopkins University2024–2025

Johns Hopkins Medicine2025–2025

Sidney Kimmel Cancer Center2024–2024

Sidney Kimmel Comprehensive Cancer Center2025–2026

Top Works

OA15.05 HUDSON: An Open-Label, Multi-Drug, Biomarker-Directed Phase 2 Study in NSCLC Patients Who Progressed on Anti-PD-(L)1 Therapy

B. Besse,M.M. Awad,et al.

20229 citations

Lung Cancer Diagnosis and Treatment

Pancreatic and Hepatic Oncology Research

1209MO Neoadjuvant nivolumab and nivolumab+ipilimumab in resectable non-small cell lung cancer: Combined analysis of 5-year outcomes from NEOSTAR and CA209-159

Joshua E. Reuss,Cheuk Hong Leung,et al.

20241 citations

P1.11.72 Phase II Study of Combination Azacitidine and Entinostat and Nivolumab in Patients With Metastatic Non-Small Cell Lung Cancer

K.A. Marrone,Bruce E. Landon,et al.

20250 citations

OA12.03 Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Resectable Diffuse Pleural Mesothelioma

J. Reuss,Reza J. Mehran,et al.

20250 citations

MA09.04 Differential CD8+FoxP3+ T Cell Infiltration Patterns Associate with Pathologic Response after Neoadjuvant Anti-PD-1 in NSCLC

Michael Fotheringham,B. Green,et al.

20240 citations

LBA1 Ceralasertib (C) + durvalumab (D) in patients (pts) with locally advanced (LA) or metastatic (m) NSCLC who progressed on or after anti-PD-(L)1 and platinum-based chemotherapy (CT): Results from LATIFY

B. Besse,E. Felip,et al.

20260 citations